Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | npj Vaccines | journal | 3.197 Q1 | 47 | 166 | 304 | 8553 | 2772 | 293 | 9.34 | 51.52 | 45.16 | |
2 | Alimentary Pharmacology and Therapeutics | journal | 2.786 Q1 | 207 | 522 | 1515 | 14017 | 5399 | 668 | 3.31 | 26.85 | 39.55 | |
3 | Journal of Biomedical Science | journal | 2.520 Q1 | 110 | 104 | 277 | 10355 | 3322 | 277 | 11.04 | 99.57 | 41.52 | |
4 | npj Breast Cancer | journal | 2.209 Q1 | 46 | 131 | 261 | 6079 | 1530 | 254 | 5.44 | 46.40 | 52.08 | |
5 | Drugs | journal | 2.093 Q1 | 188 | 146 | 521 | 9228 | 5194 | 502 | 9.73 | 63.21 | 35.53 | |
6 | Rheumatology | journal | 1.721 Q1 | 198 | 729 | 1911 | 18587 | 7531 | 1268 | 3.66 | 25.50 | 45.40 | |
7 | Acta Pharmacologica Sinica | journal | 1.677 Q1 | 117 | 274 | 533 | 16175 | 4405 | 526 | 9.15 | 59.03 | 45.34 | |
8 | BioDrugs | journal | 1.646 Q1 | 79 | 52 | 175 | 4072 | 1107 | 166 | 6.85 | 78.31 | 48.88 | |
9 | European Heart Journal - Cardiovascular Pharmacotherapy | journal | 1.641 Q1 | 40 | 108 | 264 | 3047 | 1023 | 143 | 3.84 | 28.21 | 24.36 | |
10 | CNS Drugs | journal | 1.485 Q1 | 129 | 87 | 271 | 7209 | 1641 | 262 | 5.81 | 82.86 | 42.96 | |
11 | Cochrane Database of Systematic Reviews | journal | 1.476 Q1 | 327 | 568 | 2755 | 68360 | 12943 | 2694 | 4.64 | 120.35 | 50.46 | |
12 | International Journal of Neuropsychopharmacology | journal | 1.406 Q1 | 125 | 96 | 224 | 5694 | 1192 | 216 | 4.93 | 59.31 | 39.88 | |
13 | Journal of Antimicrobial Chemotherapy | journal | 1.382 Q1 | 221 | 506 | 1656 | 17019 | 7880 | 1421 | 4.89 | 33.63 | 48.96 | |
14 | CNS Neuroscience and Therapeutics | journal | 1.381 Q1 | 91 | 215 | 416 | 11129 | 2529 | 372 | 5.37 | 51.76 | 43.87 | |
15 | Antimicrobial Resistance and Infection Control | journal | 1.367 Q1 | 66 | 159 | 566 | 5684 | 3682 | 556 | 5.47 | 35.75 | 48.63 | |
16 | Molecular Therapy - Oncolytics | journal | 1.339 Q1 | 42 | 154 | 420 | 9805 | 2379 | 420 | 5.60 | 63.67 | 40.14 | |
17 | Expert Opinion on Investigational Drugs | journal | 1.290 Q1 | 117 | 106 | 353 | 10300 | 1865 | 325 | 5.05 | 97.17 | 40.33 | |
18 | Clinical Pharmacokinetics | journal | 1.238 Q1 | 184 | 125 | 359 | 6263 | 1762 | 324 | 4.36 | 50.10 | 38.12 | |
19 | Journal of Psychopharmacology | journal | 1.120 Q1 | 135 | 131 | 441 | 8547 | 1884 | 421 | 4.02 | 65.24 | 45.35 | |
20 | Orphanet Journal of Rare Diseases | journal | 1.120 Q1 | 136 | 433 | 1140 | 17990 | 4502 | 1099 | 3.60 | 41.55 | 54.54 | |
21 | Drug Safety | journal | 1.105 Q1 | 140 | 112 | 372 | 5203 | 1487 | 326 | 3.51 | 46.46 | 45.87 | |
22 | Therapeutic Advances in Respiratory Disease | journal | 1.092 Q1 | 50 | 66 | 200 | 3170 | 833 | 189 | 4.31 | 48.03 | 39.96 | |
23 | Pharmacoepidemiology and Drug Safety | journal | 1.067 Q1 | 109 | 152 | 596 | 4511 | 1521 | 555 | 2.45 | 29.68 | 49.94 | |
24 | Advanced Therapeutics | journal | 1.039 Q1 | 39 | 93 | 333 | 7811 | 1660 | 328 | 4.74 | 83.99 | 39.14 | |
25 | Expert Review of Neurotherapeutics | journal | 0.995 Q1 | 98 | 85 | 343 | 7990 | 1417 | 304 | 3.81 | 94.00 | 41.81 | |
26 | HIV Medicine | journal | 0.989 Q1 | 86 | 138 | 312 | 4543 | 841 | 282 | 2.81 | 32.92 | 53.19 | |
27 | British Journal of Clinical Pharmacology | journal | 0.941 Q1 | 167 | 532 | 1075 | 22774 | 3615 | 910 | 3.25 | 42.81 | 44.85 | |
28 | Expert Opinion on Emerging Drugs | journal | 0.891 Q1 | 54 | 35 | 96 | 3238 | 316 | 90 | 3.40 | 92.51 | 36.54 | |
29 | Expert Review of Clinical Pharmacology | journal | 0.871 Q1 | 60 | 125 | 373 | 9993 | 1529 | 338 | 4.24 | 79.94 | 41.42 | |
30 | Drugs and Aging | journal | 0.865 Q1 | 109 | 78 | 283 | 4961 | 985 | 271 | 2.60 | 63.60 | 51.37 | |
31 | American Journal of Cardiovascular Drugs | journal | 0.841 Q2 | 60 | 63 | 177 | 2606 | 543 | 168 | 3.26 | 41.37 | 29.88 | |
32 | Expert Review of Anticancer Therapy | journal | 0.841 Q2 | 85 | 125 | 346 | 9386 | 1087 | 306 | 2.84 | 75.09 | 39.72 | |
33 | Pharmaceutical Statistics | journal | 0.832 Q2 | 46 | 94 | 228 | 2875 | 306 | 211 | 1.41 | 30.59 | 32.43 | |
34 | Paediatric Drugs | journal | 0.818 Q2 | 70 | 58 | 148 | 4262 | 622 | 142 | 4.13 | 73.48 | 54.15 | |
35 | Trials | journal | 0.814 Q2 | 98 | 1030 | 2718 | 41630 | 6431 | 2565 | 2.24 | 40.42 | 49.27 | |
36 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.800 Q2 | 13 | 17 | 41 | 972 | 137 | 37 | 2.87 | 57.18 | 45.24 | |
37 | Cardiovascular Therapeutics | journal | 0.790 Q2 | 54 | 67 | 124 | 3211 | 463 | 124 | 3.09 | 47.93 | 40.63 | |
38 | Therapeutic Advances in Cardiovascular Disease | journal | 0.784 Q2 | 41 | 13 | 47 | 643 | 175 | 43 | 2.37 | 49.46 | 33.78 | |
39 | Expert Opinion on Drug Safety | journal | 0.773 Q2 | 90 | 143 | 414 | 9964 | 1467 | 384 | 3.19 | 69.68 | 42.42 | |
40 | AIDS Research and Therapy | journal | 0.740 Q2 | 49 | 69 | 205 | 2803 | 520 | 205 | 2.25 | 40.62 | 49.85 | |
41 | Therapeutic Advances in Drug Safety | journal | 0.715 Q2 | 46 | 34 | 97 | 1643 | 352 | 82 | 3.71 | 48.32 | 53.85 | |
42 | Expert Opinion on Pharmacotherapy | journal | 0.702 Q2 | 93 | 203 | 693 | 15953 | 2053 | 596 | 2.71 | 78.59 | 40.47 | |
43 | Clinical Drug Investigation | journal | 0.680 Q2 | 67 | 107 | 351 | 3974 | 894 | 320 | 2.87 | 37.14 | 41.85 | |
44 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.650 Q2 | 57 | 33 | 201 | 1490 | 505 | 194 | 2.67 | 45.15 | 29.46 | |
45 | Pharmaceutical Medicine | journal | 0.636 Q2 | 25 | 31 | 113 | 1450 | 256 | 99 | 2.16 | 46.77 | 45.61 | |
46 | European Journal of Contraception and Reproductive Health Care | journal | 0.621 Q2 | 53 | 77 | 235 | 2485 | 459 | 214 | 1.93 | 32.27 | 60.86 | |
47 | Fundamental and Clinical Pharmacology | journal | 0.609 Q2 | 85 | 102 | 267 | 5295 | 730 | 240 | 2.81 | 51.91 | 47.82 | |
48 | BMC pharmacology & toxicology | journal | 0.603 Q2 | 43 | 93 | 246 | 3607 | 747 | 246 | 3.04 | 38.78 | 44.28 | |
49 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.596 Q2 | 61 | 132 | 274 | 5842 | 646 | 259 | 2.52 | 44.26 | 41.85 | |
50 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 0.568 Q2 | 46 | 47 | 97 | 2758 | 376 | 96 | 2.81 | 58.68 | 39.22 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®